We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

114 hedge funds and large institutions have $259M invested in BioSpecifics Technologies Corp. in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 51 increasing their positions, 34 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 16

2% less capital invested

Capital invested by funds: $264M → $259M (-$5.37M)

3% less funds holding

Funds holding: 117 → 114 (-3)

Holders
114
Holders Change
-3
Holders Change %
-2.56%
% of All Funds
2.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
51
Reduced
34
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
+$4.49M
2
Millennium Management
Millennium Management
New York
+$4.11M
3
AQR Capital Management
AQR Capital Management
Connecticut
+$3.28M
4
RC
Roubaix Capital
Colorado
+$2.84M
5
Allianz Asset Management
Allianz Asset Management
Germany
+$2.66M

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$9.02M
2
ECP
Elk Creek Partners
Colorado
-$4.61M
3
JAM
JW Asset Management
Florida
-$4.59M
4
EGI
EAM Global Investors
California
-$1.42M
5
EI
EAM Investors
California
-$1.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
26
ClariVest Asset Management
California
$2.34M -$31K -493 -1%
Deutsche Bank
27
Deutsche Bank
Germany
$2.17M -$608K -9,666 -21%
First Manhattan
28
First Manhattan
New York
$2.17M – – –
CCM
29
Cadence Capital Management
Massachusetts
$2.15M -$75.8K -1,205 -3%
ACA
30
Apis Capital Advisors
New York
$2M -$157K -2,500 -7%
PPA
31
Parametric Portfolio Associates
Washington
$1.9M +$205K +3,258 +11%
OAM
32
Oxford Asset Management
United Kingdom
$1.85M +$1.07M +17,016 +122%
WCM
33
Wedge Capital Management
North Carolina
$1.63M +$1.72M +27,373 New
CCMG
34
Clark Capital Management Group
Pennsylvania
$1.59M -$662K -10,527 -28%
VRS
35
Virginia Retirement Systems
Virginia
$1.51M +$441K +7,000 +38%
DCM
36
Dupont Capital Management
Delaware
$1.4M +$851K +13,520 +136%
Arrowstreet Capital
37
Arrowstreet Capital
Massachusetts
$1.32M +$1.39M +22,061 New
Citadel Advisors
38
Citadel Advisors
Florida
$1.28M +$610K +9,701 +83%
IP
39
Isthmus Partners
Wisconsin
$1.27M +$1.23M +19,546 +1,151%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$1.05M -$324K -5,151 -23%
Invesco
41
Invesco
Georgia
$1.03M -$366K -5,811 -25%
Squarepoint
42
Squarepoint
New York
$1.02M +$593K +9,419 +122%
Russell Investments Group
43
Russell Investments Group
United Kingdom
$983K -$133K -2,108 -11%
NA
44
Navellier & Associates
Nevada
$974K +$34.9K +554 +4%
Two Sigma Investments
45
Two Sigma Investments
New York
$782K +$824K +13,094 New
CEP
46
Chicago Equity Partners
Illinois
$753K -$10.4K -165 -1%
UBS Group
47
UBS Group
Switzerland
$711K +$209K +3,325 +39%
JP Morgan Chase
48
JP Morgan Chase
New York
$701K +$76.8K +1,220 +12%
SO
49
STRS Ohio
Ohio
$632K +$75.5K +1,200 +13%
Swiss National Bank
50
Swiss National Bank
Switzerland
$609K +$31.5K +500 +5%
1
2
3 4 5

BSTC Hedge Fund Activity: Q2 2019 in Review

114 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q2 2019, worth a combined $259M — down 2% from $264M a quarter earlier.

Fund positioning in BSTC was balanced in Q2 2019: 16 funds opened new positions, 16 closed out, 51 added to existing stakes and 34 trimmed.

The largest buyer was Nuveen, opening a new position worth an estimated $4.49M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $9.02M sold.

  • 114 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q2 2019, down from 117 in Q1 2019.
  • Funds reported $259M of BioSpecifics Technologies Corp. stock for Q2 2019, down 2% quarter-over-quarter.
  • 16 funds opened new BioSpecifics Technologies Corp. positions in Q2 2019 and 16 closed out, a net change of 0 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q2 2019 was Nuveen, an estimated $4.49M added.
  • The largest BioSpecifics Technologies Corp. seller in Q2 2019 was Acadian Asset Management, an estimated $9.02M sold.

Based on aggregated 13F filings for Q2 2019.